PAPER Wise J

Lecanemab: European drug agency upholds decision to recommend Alzheimer's drug.

BMJ. 2025 Mar 3;388:r439. PubMed.

PAPER Du X, Wang H, Liu S, Song Y, Chen X, Chen Z, Zhou R, Du J, Zhang W, Gao R, Li H, Zhang G, Mao X, Chang L, Wu Y

Astrocytic GluN2A alleviates sleep deprivation-induced elevation of Aβ through regulating neprilysin and AQP4 via the calcineurin/NFAT pathway.

Prog Neurobiol. 2025 Mar 1;:102744. Epub 2025 Mar 1 PubMed.

PAPER Wang Q, Xu L, Shan Y, Shen W, Li L, Bi XA, Liu Z

CPST-GAN: Conditional Probabilistic State Transition Generative Adversarial Network With the Biomedical Large Foundation Models.

IEEE Trans Neural Netw Learn Syst. 2025 Feb 27;PP Epub 2025 Feb 27 PubMed.

PAPER Song F, Li Y, Jiang M, Li K, Zhang J, Zhang Y, Pang Z

HSGO: Harmonized Swarm Learning With Guided Optimization for Multi-Center sMRI Classification of Alzheimer's Disease.

IEEE J Biomed Health Inform. 2025 Jan 20;PP Epub 2025 Jan 20 PubMed.

PAPER Liu Y, Liu M, Zhang Y, Guan Y, Guo Q, Xie F, Shen D

Amyloid-β Deposition Prediction with Large Language Model Driven and Task Oriented Learning of Brain Functional Networks.

IEEE Trans Med Imaging. 2025 Jan 3;PP Epub 2025 Jan 3 PubMed.

PAPER Girodon L, Hauet P

[Gut microbiome, a new tool for Alzheimer diagnosis].

Med Sci (Paris). 2025 Feb;41(2):195-197. Epub 2025 Mar 3 PubMed.

PAPER Nieves J, Gil G, Gonzalez A

A bird's eye view to the homeostatic, Alzheimer and Glioblastoma attractors.

Heliyon. 2025 Feb 28;11(4):e42445. Epub 2025 Feb 4 PubMed.

PSEN1 I162S

MUTATIONS PSEN1 73653565 GRCh37/hg19 rs1898533739 T G 73186857 GRCh38/hg38 T G Exon 6 Coding Unknown, but predicted deleterious in silico (PHRED-scaled CADD score = 26.0). Unknown. I162S Alzheimer's Disease: Not ClassifiedAlzheimer's Disease Detailed info

PSEN1 F118V

MUTATIONS PSEN1 73640287 GRCh37/hg19 T G 73173579 GRCh38/hg38 T G Exon 5 Coding Increased the Aβ42/Aβ40 ratio due to reduced Aβ40 production in cells. Unknown. F118V Alzheimer's Disease: Not ClassifiedAlzheimer's Disease Detailed information on carrier(s)

PSEN1 F105S

MUTATIONS PSEN1 73171023 GRCh37/hg19 T C 73637731 GRCh38/hg38 T C Exon 4 Coding Unknown, but predicted deleterious in silico (PHRED-scaled CADD score = 27.1). Unknown. F105S Alzheimer's Disease: Not ClassifiedAlzheimer's Disease This variant was identifie

PAPER Gordon I, Genis I, Grauer E, Sehayek E, Michaelson DM

Biochemical and cognitive studies of apolipoprotein-E-deficient mice.

Mol Chem Neuropathol. 1996;28(1-3):97-103. PubMed.

PAPER Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM

Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.

Neurosci Lett. 1995 Oct 13;199(1):1-4. PubMed.

PAPER Ueno H, Takahashi Y, Mori S, Kitano E, Murakami S, Wani K, Miyazaki T, Matsumoto Y, Okamoto M, Ishihara T

Age-related behavioural abnormalities in C57BL/6.KOR-Apoe shl mice.

Transl Neurosci. 2025 Jan 1;16(1):20220363. Epub 2025 Feb 25 PubMed.

PSEN1 V97M

MUTATIONS PSEN1 73637706 GRCh37/hg19 rs63750852 G A 73170998 GRCh38/hg38 G A Exon 4 Coding Unknown. V97M Alzheimer's Disease: Not ClassifiedAlzheimer's Disease This variant was identified in France in individual(s) who developed Alzheimer’s disease (AD) (

European Brain Barriers Meeting- 27th

CONFERENCE 2025-09-08 00:00:00-2025-09-10 00:00:00 Bern, Switzerland 08 &#x2013 10 September 2025 View Conference Website 0